Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In this section: FDA removes black box warning from popular smoking cessation drug, approves treatment for young eczema patients, greenlights drug for spinal muscular atrophy, and links a drug to higher bladder cancer risk.</p>

FDA Actions